StreetInsider.com  Jan 15  Comment 
Visit StreetInsider.com at http://www.streetinsider.com/Earnings/BioForm+%28BFRM%29+Posts+Q2+EPS+of+%240.03%2C+Beats+by+2c/5250303.html for the full story.
Globe Newswire  Jan 15  Comment 
SAN MATEO, Calif., Jan. 15, 2010 (GLOBE NEWSWIRE) -- BioForm Medical, Inc. (Nasdaq:BFRM) today announced its financial results for the quarter ended December 31, 2009, which is the Company's second quarter of fiscal 2010. Net sales were $21.8 million
Globe Newswire  Jan 5  Comment 
NEW YORK, Jan. 5, 2010 (GLOBE NEWSWIRE) -- Levi & Korsinsky is investigating the Board of Directors of BioForm Medical, Inc. ("BioForm" or the "Company") (Nasdaq:BFRM) for possible breaches of fiduciary duty and other violations of state law in
newratings.com  Jan 5  Comment 
NEW YORK, January 5 (newratings.com) - Analysts at Jefferies & Co downgrade BioForm Medical Inc (ticker: BFRM) from "buy" to "hold." The target price is set to $5.50. [more]
Globe Newswire  Jan 5  Comment 
DALLAS, Jan. 5, 2010 (GLOBE NEWSWIRE) -- StockPreacher.com announces an investment report featuring medical aesthetics company BioForm Medical Inc. (Nasdaq:BFRM). The report includes financial and investment analysis, analyst consensus, and pertinent
TheStreet.com  Jan 4  Comment 
Stocks and commodities trade higher with the dollar under pressure on Monday, the first trading session of the new year.
TheStreet.com  Jan 4  Comment 
Several stocks trading near $5 were poised to move on above-average volume during Monday's session.
TheStreet.com  Jan 4  Comment 
Monday's early headlines included several deals, including Novartis acquiring an additional 52% stake in Alcon from Nestle for about $28 billion.
TheStreet.com  Jan 4  Comment 
BioForm Medical has agreed to be acquired by privately held Merz Pharma of Frankfurt for $5.45 a share in cash, a premium of 60% to BioForm's closing price on Dec. 31.



Wikinvest © 2006, 2007, 2008, 2009, 2010, 2011, 2012. Use of this site is subject to express Terms of Service, Privacy Policy, and Disclaimer. By continuing past this page, you agree to abide by these terms. Any information provided by Wikinvest, including but not limited to company data, competitors, business analysis, market share, sales revenues and other operating metrics, earnings call analysis, conference call transcripts, industry information, or price targets should not be construed as research, trading tips or recommendations, or investment advice and is provided with no warrants as to its accuracy. Stock market data, including US and International equity symbols, stock quotes, share prices, earnings ratios, and other fundamental data is provided by data partners. Stock market quotes delayed at least 15 minutes for NASDAQ, 20 mins for NYSE and AMEX. Market data by Xignite. See data providers for more details. Company names, products, services and branding cited herein may be trademarks or registered trademarks of their respective owners. The use of trademarks or service marks of another is not a representation that the other is affiliated with, sponsors, is sponsored by, endorses, or is endorsed by Wikinvest.
Powered by MediaWiki